中国血管内超声（IVUS）系统行业市场运行态势及发展趋势预测报告

Core Viewpoint - The incidence of cardiovascular diseases in China is rising due to an aging population, and the intravascular ultrasound (IVUS) system is recognized for its clinical value in accurately assessing plaques and guiding stent implantation, thereby reducing postoperative adverse events [2][17]. Market Overview - The IVUS system is a type of interventional imaging technology that uses specially designed imaging catheters equipped with miniature ultrasound probes to obtain precise images of vascular wall structures and lumen morphology in real-time [3][18]. - The IVUS system typically consists of three components: a console, an automatic pullback device, and an imaging catheter, which work together to produce grayscale cross-sectional images of blood vessels [4][19]. Market Policy - The medical device industry, including the IVUS system, is a strategic emerging industry in China, with the government emphasizing its development through various policies aimed at ensuring product quality and patient safety [8][24]. - Key policies include the "Notice on the Management of Medical Consumables Procurement and Price Management for 2023" and the "Opinions on Further Strengthening and Improving the Classification Management of Medical Devices," among others, which create a favorable policy environment for the IVUS industry [10][26]. Industry Chain - The IVUS system industry chain is divided into three main segments: upstream core components and raw material supply, midstream equipment research and manufacturing, and downstream terminal applications, with hospitals and healthcare institutions being the primary end-users [24][30]. - The upstream segment includes suppliers of micro-ultrasound transducers, high-frequency signal processors, and specialized materials, while the midstream focuses on the research, design, and production of IVUS systems [24][30]. Demand and Market Growth - The primary demand for IVUS systems comes from patients with cardiovascular diseases, which are the leading cause of death in China, with coronary artery disease being the most common type [11][27]. - The number of coronary artery disease patients in China is projected to reach 28 million by 2024, representing a year-on-year increase of 3.70%, which is expected to drive the demand for IVUS systems [11][27]. - In 2024, the total procurement volume of IVUS systems in China is expected to reach 151 units, a year-on-year increase of 52.53%, with a total procurement amount of 159 million yuan, reflecting a growth of 26.19% [17][18].